S406b The patient was started on lamivudine, 100 mg daily. Liver function tests and HBV serology were monitored every three months. Twelve months after beginning lamivudine therapy, the following test results were obtained: Laboratory Results ALT: 32 U/L HbeAg: positive HBV DNA: undectable